Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
暂无分享,去创建一个
Theodore G. Drivas | Justine C. Williams | J. Weaver | M. Ritchie | Juliana S. Qin | A. Greenplate | S. Hensley | S. Verma | D. Weiskopf | A. Verma | R. Judy | S. Dudek | C. Clendenin | A. Grifoni | A. Baxter | A. Huang | S. Derohannessian | Alexander C. Huang | R. da Silva Antunes | D. Mathew | Josephine R. Giles | Sokratis A. Apostolidis | Stephanie L Derohannessian | A. Pattekar | O. Kuthuru | J. Dougherty | R. Goel | T. Johnston | Jefferson J. S. Santos | Nawar Naseer | Ashwin N. Skelly | E. Wherry | S. Long | Kendall A. Lundgreen | Maura McLaughlin | S. Adamski | M. Risman | Mark M. Painter | Paul Bates | Michelle L. McKeague | Bria Fulmer | Ahmad Goode | Sean Nasta | Macy Kee | Colleen Morse | Jefferson J S Santos | Juliana S Qin | Ashwin N Skelly | Laura E. Felley | Michael D. Feldman | Nawar Naseer | Afiya Poindexter | Ashlei Brock | Khadijah Hu-Sain | Yi-An Ko | Meghan Livingstone | Fred Vadivieso | Ashley Kloter | Teo Tran | Linda Morrel | Ned Haubein | Joseph Dunn | Yuki Bradford | Theodore Drivas | Cynthia Clendenin | Alessandro Sette | Daniel J Rader | Joellen Weaver | Marylyn D. Michael D. JoEllen Nawar Afiya Ashlei Khadijah Ritchie Feldman Weaver Naseer Poindexter | Teo Tran | D. J. Rader | Joellen Weaver | Daniel J. Rader
[1] M. Davenport,et al. Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis , 2023, Nature Communications.
[2] B. Pulendran,et al. Robust T cell responses to Pfizer/BioNTech vaccine compared to infection and evidence of attenuated peripheral CD8+ T cell responses due to COVID-19 , 2023, Immunity.
[3] M. Davenport,et al. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses , 2023, Immunity.
[4] D. Burton,et al. Tissue-resident memory T cells trigger rapid exudation and local antibody accumulation , 2023, Mucosal immunology.
[5] P. Cresswell,et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Nussenzweig,et al. Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination , 2022, Nature.
[7] D. Zeng,et al. Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes. , 2022, JAMA.
[8] A. Bertoletti,et al. SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity , 2022, The Journal of experimental medicine.
[9] M. Nussenzweig,et al. Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans , 2022, bioRxiv.
[10] G. Kochs,et al. COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation , 2022, Nature Communications.
[11] L. Tserel,et al. Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine , 2022, Cell Reports Medicine.
[12] F. Lund-Johansen,et al. Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults , 2022, Nature Communications.
[13] S. Honsawek,et al. Breakthrough Infection by SARS-CoV-2 Delta and Omicron Variants Elicited Immune Response Comparable to mRNA Booster Vaccination , 2022, The Journal of infectious diseases.
[14] M. Davenport,et al. The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants , 2022, Immunity.
[15] M. Peluso,et al. Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study , 2022, medRxiv.
[16] L. Walker,et al. Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection , 2022, Science Immunology.
[17] R. Milo,et al. Omicron infection enhances Delta antibody immunity in vaccinated persons , 2022, Nature.
[18] G. Kochs,et al. SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals , 2022, Nature Microbiology.
[19] M. Nussenzweig,et al. Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost , 2022, Nature.
[20] F. Tafesse,et al. Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection , 2022, Med.
[21] O. Laeyendecker,et al. SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge , 2022, JCI insight.
[22] Justine C. Williams,et al. Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine , 2022, Cell.
[23] Thomas P. Fabrizio,et al. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells , 2022, Nature Immunology.
[24] L. Madoff,et al. Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant , 2022, Science Translational Medicine.
[25] E. Wherry,et al. Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers. , 2022, Immunity.
[26] M. Koopmans,et al. Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients , 2022, Science Immunology.
[27] A. Sette,et al. Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status , 2022, Cell Host & Microbe.
[28] E. Wherry,et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals , 2022, Cell.
[29] H. Leier,et al. Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants , 2022, Science Immunology.
[30] N. Andrews,et al. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England , 2022, Nature Medicine.
[31] S. Mallal,et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron , 2022, Cell.
[32] Fei Shao,et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies , 2021, bioRxiv.
[33] S. Haneuse,et al. Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections , 2021, JCI insight.
[34] C. Caltagirone,et al. BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype , 2021, Science Immunology.
[35] Aaron M. Rosenfeld,et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern , 2021, Science.
[36] E. Wherry,et al. Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination , 2021, Immunity.
[37] H. Ljunggren,et al. Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination , 2021, The Journal of Immunology.
[38] R. Scheuermann,et al. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals , 2021, Cell Reports Medicine.
[39] A. Mehta,et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells , 2021, Cell Reports Medicine.
[40] M. Diamond,et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses , 2021, Nature.
[41] J. Liu,et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι , 2021, Proceedings of the National Academy of Sciences.
[42] M. Davenport,et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection , 2021, Nature Medicine.
[43] Aaron M. Rosenfeld,et al. Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination , 2021, Science Immunology.
[44] S. Mallal,et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2021, Cell Reports Medicine.
[45] J. Hurley,et al. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein , 2020, Proceedings of the National Academy of Sciences.
[46] P. Dormitzer,et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses , 2020, Nature.
[47] J. Greenbaum,et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.
[48] Jeffrey S. Morris,et al. SARS-CoV-2 seroprevalence among parturient women in Philadelphia , 2020, Science Immunology.
[49] S. Hoffman,et al. Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response. , 2020, Cell host & microbe.
[50] J. Greenbaum,et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.
[51] Thomas Becker,et al. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2 , 2020, Science.
[52] E. Harris,et al. Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort , 2016, Proceedings of the National Academy of Sciences.
[53] Paul G. Thomas,et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells , 2015, Nature Communications.
[54] E. Wherry,et al. Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity , 2013, PLoS pathogens.
[55] F. Marincola,et al. A human memory T-cell subset with stem cell-like properties , 2011, Nature Medicine.
[56] M. Vlková,et al. Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination. , 2011, Vaccine.
[57] E. Walsh,et al. Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. , 2010, Vaccine.
[58] S. Plotkin,et al. Vaccines: correlates of vaccine-induced immunity. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] Ravi S. Misra,et al. B Cells Promote Resistance to Heterosubtypic Strains of Influenza via Multiple Mechanisms1 , 2008, The Journal of Immunology.
[60] E. Wherry,et al. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. , 2007, Immunity.
[61] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[62] M. Rep,et al. Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.
[63] K. McCoy,et al. The immune geography of IgA induction and function , 2008, Mucosal Immunology.